AITX Pushes Cash Breakeven to January 2027, Expands Cost Cuts Past $350K/Month
AITX sits 20% above its 52-week low of $0.001 on elevated volume (3.6× avg).
Summary
AITX pushed its monthly operating cash breakeven target to January 2027 from December 2026 while expanding cost cuts to over $350,000 per month by February 2027, and set a Q2 2027 all-in breakeven goal. The plan relies on 2.7% monthly revenue growth and includes deferred salary that remains owed.
Key Events · Earnings and Guidance · AITX
-
Breakeven Target Slipped to January 2027
Monthly operating cash breakeven is now projected for January 2027, one month later than the December 2026 goal set in August, due to one-time separation costs and the phased rollout of cuts.
-
Cost Savings Expanded Past $350K/Month
The cash savings program replaces the prior $200,000 monthly target, reaching about $345,000 per month in January 2027 and exceeding $350,000 from February 2027 versus the August 2026 expense run rate.
-
All-In Breakeven Set for Q2 2027
A second milestone targets all-in cash breakeven in the second calendar quarter of 2027, covering scheduled debt service and device build costs; timing depends heavily on inventory cash needs.
-
Savings Include Deferred Salary Still Owed
Salary deferrals and deferred compensation remain obligations of the company and are not permanent expense reductions; paying them will require cash and could affect either breakeven milestone.
Analysis · AITX · Technology
AITX told investors its monthly operating cash breakeven slips from December 2026 to January 2027, but it is deepening the cost program to roughly $345,000 per month by January and more than $350,000 from February, measured against its August 2026 run rate. The company also set a second, harder milestone — all-in cash breakeven in Q2 calendar 2027 that includes debt service and device builds. The catch is that part of the savings is deferred salary, which remains owed and must eventually be paid in cash, and the projection leans on 2.7% monthly revenue growth that exceeds its trailing-twelve-month pace. With the auditor's going-concern doubt and cash insufficient for an extended period without financing, hitting January depends on revenue and cost assumptions holding; missing it would leave the company reliant on further dilutive raises.
How filings like this one have moved
In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AITX was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $796.1K. The 52-week trading range was $0.00 to $0.12. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.